Each quarter, we provide a look at federal lobbying disclosures by psychedelic drug developers and nonprofits. That data is a lagging indicator, especially as filings are not required immediately at the end of each quarter. The data is available via our Psychedelics Federal Lobbying Tracker. Below is our analysis of the latest developments for our Pα+ subscribers. Here’s a review of Q3 2025…
